fbpx

Michael Burry vs Institutional Outlook

Your capital is at risk if you invest. You could lose all your investment. Please see the full risk warning here.

Websim is the retail division of Intermonte, the primary intermediary of the Italian stock exchange for institutional investors. Leverage Shares often features in its speculative analysis based on macros/fundamentals. However, the information is published in Italian. To provide better information for our non-Italian investors, we bring to you a quick translation of the analysis they present to Italian retail investors. To ensure rapid delivery, text in the charts will not be translated. The views expressed here are of Websim. Leverage Shares in no way endorses these views. If you are unsure about the suitability of an investment, please seek financial advice. View the original at

Many investors would be aware of the name “Michael Burry”. An eccentric doctor-turned-trader, Michael Burry shot to fame after correctly predicting the 2008 subprime mortgage crisis that triggered the Great Recession. His decision to short the subprime market made him and his investors around $100 million and $700 million in profits respectively. He was made even more famous after being featured in Michael Lewis’ book “The Big Short”, which was then adapted into a blockbuster Hollywood movie with Christian Bale assaying his character. Since then, he’s become an online celebrity of sorts prone to posting (and then scrubbing) extremely terse comments on Twitter under the username “Cassandra B.C.”. The username is itself a reference to the Apollo-worshipping Trojan priestess from Greek mythology fated to utter true prophecies but never to be believed. As an investor renowned for making short bets, this appellation might even be considered rather apropos.

Securities filing from last week showed that Dr. Burry has held bearish put options against shares tracking the S&P 500 and Nasdaq 100 indices worth a combined $1.6 billion at the end of the second quarter. However, what news media have often failed to report is that this is the value of the underlying and not the amount spent on buying said options Furthermore, there are no details about the strike price or time to maturity. Dr. Burry’s investment management firm, Scion Asset Management, had a little under $238 million in assets under management (AUM) as of end of Q1 2023.

Furthermore, unlike the Trojan priestess, not every one of Dr. Burry’s predictions have held true.

His most recent major prophecy involved a simple statement of “Sell” made via Twitter in January this year, which didn’t hold true. Dr. Burry later withdrew this tweet. This time, however, his Twitter (now “X”) account is shuttered and the actual act of “skin in the game” was revealed via filings.

There is, of course, some rationale behind Dr. Burry’s decision to be bearish. Several articles in the Year to Date (YTD) have highlighted the fact that all is not well in the global macroeconomic outlook for most of the Developed Market economies, where fundamentals have been rather muddled. Nowhere is this truer than in the U.S. As per a report released by Bank of America a little before Dr. Burry’s filings were made known, the United States government is poised to accrue debt at a rate of a staggering $5.2 billion a day for the next 10 years.

The relative tightness and overdependence on US debt can also be indirectly assessed by US crude oil reserves, including the Strategic Petroleum Reserve, are at lows not seen since 1985 and are even lower after the massive selloff executed in 2021-2022.

With the U.S. Federal Reserve intent on hiking rates, this means that the US government’s share of debt being issued to pay past debt will likely continue to grow. US 30-Year Treasury debt is trading in a “Goldilocks” range, signaling a turnaround to increasing attractiveness relative to US equity markets.

Unsurprisingly, Fitch had downgraded the US in early August citing a steady deterioration in standards of governance over the last 20 years, including on fiscal and debt matters. On the 15th, Fitch also warned it might have to downgrade a slew of US banks including giants like JPMorgan. This was to be expected, given that Moody’s had slashed credit ratings on 10 US banks and 11 other lenders at around the same time.

This has consequences in the private market space as well. “Insurtech” startups and ventures, which had traditionally been highly valued, are estimated to be at 5-year lows with respect to funding as well as a general drop in volumes. “Insurtech” Mergers & Acquisition (M&A) exits have grown 45% Quarter-on-Quarter, almost completely reversing a recent slowdown.

Investors have been shoring up their investments in privately-held growth companies; with early figures at H1 already well past those for the entirety of 2022.

Despite this, Bank of America reports that tech inflows into the tech sector have been seen an increase in the past couple of weeks, despite a general downturn in valuations.

This could be considered to be more along the lines of a “flight to safety” towards large- and mega-cap tech companies who are deemed as being more “survivable” on account of their liquidity. This assertion is borne out by the fact that tech valuations have been declining in the private markets, especially in later-stage investment rounds.

In the tech valuation landscape for Q2, the standout facts that remain are:

  • Median tech valuations dropped again quarter-over-quarter (QoQ) for Series A (-14%), Series C (-9%), and Series D+ (-33%) startups.

  • The later the stage, the sharper the valuation decline year-over-year (YoY) in Q2’23. While the median valuation for seed/angel and Series A rounds fell 15% and 29% YoY, respectively, Series B to Series D+ valuations tumbled between 30% and 60%.

  • Deals negotiated with seniority or tiered liquidation structures gained share across every stage from Series A to Series D+ in H1’23.

  • Over half (60.6%) of Series D+ deals had seniority or tiered liquidation structures in H1’23.

Juxtaposing the two scenarios together brings out a worrying picture: “Big Tech” is expected to be bigger, with very few newcomers (if any) foreseen as being capable of accruing value by outright competition.

Overall, flows into Emerging Markets (EM) equities have been outstripping flows into Developed Markets (DM) economies. The biggest beneficiaries to this have been, of course, Chinese and Indian equities.

However, it bears noting that the flows into Chinese equities are essentially making up for outflows seen during 2022 as geopolitical tensions were ratcheting. The rise in flows towards Indian equities, however, is a new development. Traditionally, a small number of foreign investors have remained resolute in managing their holdings: these new inflows signify growing attention.

Of all types of markets and strategies, European equities and long-only funds come out the worse for wear so far. The latter highlights the adoption of a tactical mindset among institutional investors by cashing in on dip/rise situations. Rising rates have also made bank loans and government bonds increasingly attractive for said investors. The outsized shift away from commodities, in the meantime, is yet another factor indicating that recessionary pressures aren’t off the table. In a recessionary outlook, consumption is expected to dip. Therefore, the commodities outlook turns bearish.

All in all, Bank of America – unlike Dr. Burry – concludes on a “Neutral” signal on its “Bulls & Bears Indicator”, which is an accurate assessment of the state of markets. Tech narratives continue to be shaky, and the consumption outlook will continue to decline (as evidenced by the reports from Disney and Target, among others), while sector rotation is bound to continue to smooth out market concentration, and Emerging Markets — led by India and China — will continue to garner interest.

The rising utilization of tactical trading instruments such as leveraged products by institutional investors to cash in on tactical opportunities and firm up balance sheets should also be borne in mind in the weeks and quarters to come. For professional investors, there is a wealth of Exchange-Traded Products (ETPs) to choose from: SP5Y gives leveraged exposure to the upside of the S&P 500 while SPYS does the same on the downside, QQQ3 gives leveraged exposure to the upside of the Nasdaq-100 while QQ3S does the same on the downside, CHI3 gives a 3X exposure to the upside of the Chinese market while CHNS gives a 3X exposure to the downside, and IND3 gives a 3X daily-rebalanced exposure to the upside of the iShares MSCI India ETF while INDS does the same on the downside.

Your capital is at risk if you invest. You could lose all your investment. Please see the full risk warning here.

Related Posts

Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Violeta-540x540-1.jpg
Sandeep Rao
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Violeta-540x540-1.jpg
Violeta Todorova
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
Violeta-540x540-1.jpg
Boyan Girginov
March’s CPI rise undermines the Fed’s hopes for a soft landing.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
Stocks are off to a rough start in the new quarter as inflation persists.
Stocks are off to a rough start in the new quarter as inflation persists.
Violeta-540x540-1.jpg
Violeta Todorova
Stocks are off to a rough start in the new quarter as inflation persists.
Stocks are off to a rough start in the new quarter as inflation persists.
Stocks are off to a rough start in the new quarter as inflation persists.
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Violeta-540x540-1.jpg
Sandeep Rao
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Q2 is poised for European stocks’ turnaround and rising interest in energy stocks
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Violeta-540x540-1.jpg
Violeta Todorova
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
Escalation of the conflict in the Middle East threatens to derail the economic recovery.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
Violeta-540x540-1.jpg
Boyan Girginov
March’s CPI rise undermines the Fed’s hopes for a soft landing.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
March’s CPI rise undermines the Fed’s hopes for a soft landing.
Stocks are off to a rough start in the new quarter as inflation persists.
Stocks are off to a rough start in the new quarter as inflation persists.
Violeta-540x540-1.jpg
Violeta Todorova
Stocks are off to a rough start in the new quarter as inflation persists.
Stocks are off to a rough start in the new quarter as inflation persists.
Stocks are off to a rough start in the new quarter as inflation persists.

Sandeep Rao

Research

Sandeep joined Leverage Shares in September 2020. He leads research on existing and new product lines, asset classes, and strategies, with special emphasis on analysis of recent events and developments.

Sandeep has longstanding experience with financial markets. Starting with a Chicago-based hedge fund as a financial engineer, his career has spanned a variety of domains and organizations over a course of 8 years – from Barclays Capital’s Prime Services Division to (most recently) Nasdaq’s Index Research Team.

Sandeep holds an M.S. in Finance as well as an MBA from Illinois Institute of Technology Chicago.

Violeta Todorova

Senior Research

Violeta joined Leverage Shares in September 2022. She is responsible for conducting technical analysis, macro and equity research, providing valuable insights to help shape investment strategies for clients.

Prior to joining LS, Violeta worked at several high-profile investment firms in Australia, such as Tollhurst and Morgans Financial where she spent the past 12 years of her career.

Violeta is a certified market technician from the Australian Technical Analysts Association and holds a Post Graduate Diploma of Applied Finance and Investment from Kaplan Professional (FINSIA), Australia, where she was a lecturer for a number of years.

Julian Manoilov

Marketing Lead

Julian joined Leverage Shares in 2018 as part of the company’s primary expansion in Eastern Europe. He is responsible for web content and raising brand awareness.

Julian has been academically involved with economics, psychology, sociology, European politics & linguistics. He has experience in business development and marketing through business ventures of his own.

For Julian, Leverage Shares is an innovator in the field of finance & fintech, and he always looks forward with excitement to share the next big news with investors in the UK & Europe.

Oktay Kavrak

Head of Communications and Strategy

Oktay joined Leverage Shares in late 2019. He is responsible for driving business growth by maintaining key relationships and developing sales activity across English-speaking markets.

He joined Leverage Shares from UniCredit, where he was a corporate relationship manager for multinationals. His previous experience is in corporate finance and fund administration at firms like IBM Bulgaria and DeGiro / FundShare.

Oktay holds a BA in Finance & Accounting and a post-graduate certificate in Entrepreneurship from Babson College. He is also a CFA charterholder.

Q2 2024 Market Outlook: Rocky Road Ahead

S&P 500 Plunges on Rising Middle East Tension

Goldman Posts Unexpected Surge in Profits

What is an ETF? (Exchange Traded Fund)

How do Leverage Shares ETPs differ from other leveraged ETP issuers

How Do Leverage Shares ETPs Trade in Multiple Currencies

Build your own ETP Basket
Leverage Shares: Europe’s top leveraged and inverse ETP provider.
Main ETP benefits
Common investor questions

Get the Newsletter

Never miss out on important announcements. Get premium content ahead of the crowd. Enjoy exclusive insights via the newsletter only.

Welcome to Leverage Shares

Terms and Conditions

Notice

If you are not classified as an institutional investor, you will be categorised as a private/retail investor. At this time, we cannot send communications directly to private/retail investors. You are welcome to view the contents of this website.

If you are an ‘Institutional investor’, you affirm either that you are a Per Se Professional Client, or that you wish to be treated as an Eligible Counterparty Client, both as defined under the Markets in Financial Instruments Directive, or an equivalent in a jurisdiction outside the European Economic Area.

Risk Warnings

The value of an investment in ETPs may go down as well as up and past performance is not a reliable indicator of future performance. Trading in ETPs may not be suitable for all types of investor as they carry a high degree of risk. You may lose all of your initial investment. Only speculate with money you can afford to lose. Changes in exchange rates may also cause your investment to go up or down in value. Tax laws may be subject to change. Please ensure that you fully understand the risks involved. If in any doubt, please seek independent financial advice. Investors should refer to the section entitled “Risk Factors” in the relevant prospectus for further details of these and other risks associated with an investment in the securities offered by the Issuer.

This website is provided for your general information only and does not constitute investment advice or an offer to sell or the solicitation of an offer to buy any investment.

Nothing on this website is advice on the merits of any product or investment, nothing constitutes investment, legal, tax or any other advice nor is it to be relied on in making an investment decision. Prospective investors should obtain independent investment advice and inform themselves as to applicable legal requirements, exchange control regulations and taxes in their jurisdiction.

This website complies with the regulatory requirements of the United Kingdom. There may be laws in your country of nationality or residence or in the country from which you access this website which restrict the extent to which the website may be made available to you.

United States Visitors

The information provided on this site is not directed to any United States person or any person in the United States, any state thereof, or any of its territories or possessions.

Persons accessing this website in the European Economic Area

Access to this site is restricted to Non-U.S. Persons outside the United States within the meaning of Regulation S under the U.S. Securities Act of 1933, as amended (the “Securities Act”). Each person accessing this site, by so doing, acknowledges that: (1) it is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities. None of the funds on this website are registered under the United States Investment Advisers Act of 1940, as amended (the “Advisers Act”).

Exclusion of Liability

Certain documents made available on the website have been prepared and issued by persons other than Leverage Shares Management Company. This includes any Prospectus document. Leverage Shares Management Company is not responsible in any way for the content of any such document. Except in those cases, the information on the website has been given in good faith and every effort has been made to ensure its accuracy. Nevertheless, Leverage Shares Management Company shall not be responsible for loss occasioned as a result of reliance placed on any part of the website and it makes no guarantee as to the accuracy of any information or content on the website. The description of any ETP Security referred to in this website is a general one. The terms and conditions applicable to investors will be set out in the Prospectus, available on the website and should be read prior to making any investment.

Leverage Investment

Leverage Shares exchange-traded products (ETPs) provide leveraged exposure and are only suitable for experienced investors with knowledge of the risks and potential benefits of leveraged investment strategies.

Cookies

Leverage Shares Management Company may collect data about your computer, including, where available, your IP address, operating system and browser type, for system administration and other similar purposes (click here for more information). These are statistical data about users’ browsing actions and patterns, and they do not identify any individual user of the website. This is achieved by the use of cookies. A cookie is a small file of letters and numbers that is put on your computer if you agree to accept it. By clicking ‘I agree’ below, you are consenting to the use of cookies as described here. These cookies allow you to be distinguished from other users of the website, which helps Leverage Shares Company provide you with a better experience when you browse the website and also allows the website to be improved from time to time. Please note that you can adjust your browser settings to delete or block cookies, but you may not be able to access parts of our website without them.

This website is maintained by Leverage Shares Management Company, which is a limited liability company and is incorporated in Ireland with registered offices at 2 Grand Canal Square, Grand Canal Harbour, Dublin 2. 

By clicking you agree to the Terms and Conditions displayed.